{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:15:35Z","timestamp":1773904535130,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10620-020-06773-7","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T21:35:11Z","timestamp":1610400911000},"page":"4436-4440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-\u03b1 Antagonists"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4706-6168","authenticated-orcid":false,"given":"Cassandra M.","family":"Townsend","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reena","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aze Suzanne","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"6773_CR1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/jcag\/gwz019","volume":"2","author":"R Panaccione","year":"2019","unstructured":"Panaccione R, Steinhart AH, Bressler B, et al. Canadian Association of Gastroenterology Clinical Practice Guidelines for the Management of Luminal Crohn\u2019s Disease. J Can Assoc Gastroenterol. 2019;2:e1\u2013e34.","journal-title":"J Can Assoc Gastroenterol"},{"key":"6773_CR2","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1093\/ecco-jcc\/jjv032","volume":"9","author":"A Algaba","year":"2015","unstructured":"Algaba A, Guerra I, Mar\u00edn-Jim\u00e9nez I, Quintanilla E, et al. Incidence, management, and course of cancer in patients with inflammatory bowel disease. J Crohn\u2019s Colitis. 2015;9:326\u2013333.","journal-title":"J Crohn\u2019s Colitis"},{"key":"6773_CR3","unstructured":"Ferlay J, Ervik M, Lam F et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer; 2018. Available at: https:\/\/gco.iarc.fr\/today. Accessed 14 June 2020."},{"key":"6773_CR4","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jaad.2017.10.007","volume":"78","author":"M Alam","year":"2018","unstructured":"Alam M, Armstrong A, Baum C, et al. Guidelines of care for the management of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2018;78:560\u2013578.","journal-title":"J Am Acad Dermatol"},{"key":"6773_CR5","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.jaad.2017.10.006","volume":"78","author":"C Bichakjian","year":"2018","unstructured":"Bichakjian C, Armstrong A, Baum C, et al. Guidelines of care for the management of basal cell carcinoma. J Am Acad Dermatol. 2018;78:540\u2013559.","journal-title":"J Am Acad Dermatol"},{"key":"6773_CR6","doi-asserted-by":"publisher","first-page":"574","DOI":"10.6004\/jnccn.2016.0065","volume":"14","author":"CK Bichakjian","year":"2016","unstructured":"Bichakjian CK, Olencki T, Aasi SZ, et al. NCCN Clinical Practice Guidelines in Oncology, Basal Cell Cancer, Version 1.2016. J Natl Compr Cancer Netw. 2016;14:574\u2013597.","journal-title":"J Natl Compr Cancer Netw"},{"key":"6773_CR7","unstructured":"National Comprehensive Cancer Center. NCCN clinical practice guidelines in oncology; squamous cell carcinoma (V1.2018). Available at: www.nccn.org. Accessed October 3, 2019."},{"key":"6773_CR8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","volume":"143","author":"MB Long","year":"2012","unstructured":"Long MB, Martin CF, Pipkin CA, Herfarth HH, Sandler RS, Kappelman MD. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology. 2012;143:390\u2013399.","journal-title":"Gastroenterology"},{"key":"6773_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u2013381.","journal-title":"J Biomed Inform"},{"key":"6773_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al. REDCap consortium, the REDCap consortium: building an international community of software partners. J Biomed Inform. 2019. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Biomed Inform"},{"key":"6773_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jaad.2014.09.036","volume":"72","author":"C Karimkhani","year":"2015","unstructured":"Karimkhani C, Boyers L, Dellavalle RP, Weinstock MA. It\u2019s time for \u201ckeratinocyte carcinoma\u201d to replace the term \u201cnonmelanoma skin cancer\u201d. J Am Acad Dermatol. 2015;72:186\u2013187.","journal-title":"J Am Acad Dermatol"},{"key":"6773_CR12","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/ibd.20520","volume":"14","author":"JD Lewis","year":"2008","unstructured":"Lewis JD, Chuai S, Nessel L, Lichtenstein GR, Aberra FN, Ellenberg JH. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008;14:1660\u20131666.","journal-title":"Inflamm Bowel Dis"},{"key":"6773_CR13","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","volume":"315","author":"RF Harvey","year":"1980","unstructured":"Harvey RF, Bradshaw JM. A simple index of Crohn\u2019s-disease activity. Lancet. 1980;315:514.","journal-title":"Lancet"},{"key":"6773_CR14","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1053\/gast.2002.31072","volume":"122","author":"WJ Sandborn","year":"2002","unstructured":"Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn\u2019s disease. Gastroenterology. 2002;122:512\u2013530.","journal-title":"Gastroenterology"},{"key":"6773_CR15","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1053\/j.gastro.2011.06.050","volume":"141","author":"L Peyrin-Biroulet","year":"2011","unstructured":"Peyrin-Biroulet L, Khosrotehrani K, Carrat F, et al. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology. 2011;141:1621\u20131628.","journal-title":"Gastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06773-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-020-06773-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06773-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T18:17:26Z","timestamp":1636741046000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-020-06773-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6773"],"URL":"https:\/\/doi.org\/10.1007\/s10620-020-06773-7","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"assertion":[{"value":"16 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Cassandra Townsend and Dr. Aze Wilson declare that they have no conflicts of interest with this work. Dr. Reena Khanna has received consultancy fees from AbbVie, Encycle Innomar, Lilly, Janssen, Merck, Pfizer, Roche, Takeda, Amgen; Speaker fees from AbbVie, Lilly, Janssen, Pendopharm, Roche, Shire, Takeda; Research study fees from Roche.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}